Neyssa Marina

Medicine · Health Sciences

65h-index17.8kcitations296works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(111), Childhood Cancer Survivors' Quality of Life(49), Neuroblastoma Research and Treatments(45), Testicular diseases and treatments(44), Lymphoma Diagnosis and Treatment(36)

Publications291 total

1461 Phase 2 randomized study of domvanalimab combined with zimberelimab in front-line, PD-(L)1 high, locally advanced or metastatic non-small cell lung cancer (NSCLC): results from ARC-10 part 1
2024· 5 citedOpen Access
196 Utilizing pharmacokinetic (PK) and pharmacodynamic (PD) biomarkers to support recommended phase 2 dose (RP2D) selection for phase 1 study of SAR444245 (SAR’245) in patients with advanced solid tumors
Regular and Young Investigator Award Abstracts·2024Open Access
Abstract 2155: Joint modeling of safety and peripheral mode-of-action (MoA) biomarkers to support RP2D identification in Phase 1 study of SAR444245 (SAR’245) as monotherapy (mono) or combined with pembrolizumab (pembro) in patients with advanced solid tumors
Cancer Research·2023· 1 cited
Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 6 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 4 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 2 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Data from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Figures 1 - 11 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 1 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 5 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 1 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 4 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 3 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 2 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Table 6 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Supplementary Figures 1 - 11 from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Data from A Genome-Wide Scan Identifies Variants in <i>NFIB</i> Associated with Metastasis in Patients with Osteosarcoma
2023Open Access
Erratum to ‘Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma’ [Eur J Cancer 170 (2022) 209-235]
European Journal of Cancer·2022Open Access
page 1 of 15Next →

Frequent Co-authors

Mark Krailo(15), Richard Görlick(13), Mark L. Bernstein(11), Holcombe E. Grier(11), Mark C. Gebhardt(8), R. Lor Randall(8), Richard B. Womer(8), Paul A. Meyers(7), Melissa M. Hudson(6), Jeremy Whelan(6), Stephen J. Lauer(6), Cindy L. Schwartz(5), Sigbjørn Smeland(5), Stefan Bielack(5), Pancras C.W. Hogendoorn(5), Katherine A. Janeway(5), Trude Butterfaß‐Bahloul(5), Gabriele Calaminus(5), Hans Gelderblom(5), Stephen L. Lessnick(5)